The percentage of patients on dialysis with a mean
iPTH > 400 pg/mL and > 600 pg/mL have risen since October 20102
De-identified patient data from large and small dialysis organizations are shared with Amgen each month per contractual agreement. These data are reported cross-sectionally and from a report known as OutcomesPlus. The OutcomesPlus database began in 2004. Data are pulled monthly. Total N varies; N for July 2012 = 274,117. Because of patient switching between dialysis organizations, some duplication in patient count may occur.2
- In a separate analysis, the DOPPS Practice Monitor data showed the percentage of patients with iPTH > 600 pg/mL increased from 11% in August 2010 to 19% in April 20123
DOPPS = Dialysis Outcomes and Practice Patterns Study.
- 2. Data on file, Amgen [OutcomesPlus Database; July 2012].
- 3. Arbor Research Collaborative for Health. Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor Featured Measures October 2012 (data through April 2012). http://www.dopps.org/DPM/Default.aspx. Accessed November 8, 2012.